维普中文期刊产品整合服务

Oxidative stress and diabetes:antioxidative strategies

查看全文 作  者:Pengju [1]Zhang;Tao [1]Li;Xingyun [1]Wu;Edouard [2]C.Nice;Canhua [1]Huang;Yuanyuan [1]Zhang 高影响力作者 机构地区:[1]Department of Pharmacology,West China School of Basic Medical Sciences&Forensic Medicine,Sichuan University,Chengdu 610041,China;[2]Department of Biochemistry and Molecular Biology,Monash University,Clayton,Victoria,Australia高影响力机构 出  处:《Frontiers of Medicine》索引2020年第14卷第5期,共18页高影响力期刊 基  金:This work was supported by grants from the National Natural Science Foundation of China(Nos.81770580,81430071,81821002,and 81790251);Sichuan Science and Technology Program(No.2018RZ0133). 摘  要:Diabetes mellitus is one of the major public health problems worldwide.Considerable recent evidence suggests that the cellular reduction-oxidation(redox)imbalance leads to oxidative stress and subsequent occurrence and development of diabetes and related complications by regulating certain signaling pathways involved in p-cell dysfunction and insulin resistance.Reactive oxide species(ROS)can also directly oxidize certain proteins(defined as redox modification)involved in the diabetes process.There are a number of potential problems in the clinical application of antioxidant therapies including poor solubility,storage instability and nonselectivity of antioxidants.Novel antioxidant delivery systems may overcome pharmacokinetic and stability problem and improve the selectivity of scavenging ROS.We have therefore focused on the role of oxidative stress and antioxidative therapies in the pathogenesis of diabetes mellitus.Precise therapeutic interventions against ROS and downstream targets are now possible and provide important new insights into the treatment of diabetes. 关 键 词:DIABETES oxidative stress redox modification antioxidative therapy novel antioxidant delivery
相关文献

参考文献(163)

引证文献(60)

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费